{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:21:10Z","timestamp":1757622070170,"version":"3.44.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SERB-TARE (TAR\/2023\/000422)"],"award-info":[{"award-number":["SERB-TARE (TAR\/2023\/000422)"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Netw Model Anal Health Inform Bioinforma"],"DOI":"10.1007\/s13721-025-00581-7","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T05:24:05Z","timestamp":1754371445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unveiling new therapeutic candidates for dystrophinopathies: computational insights into FBXO32 and CD4 modulation"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3090-6594","authenticated-orcid":false,"given":"Pooja","family":"Trivedi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4388-0488","authenticated-orcid":false,"given":"Nandan","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4919-1322","authenticated-orcid":false,"given":"Saumya","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9136-3875","authenticated-orcid":false,"given":"Sharad","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9295-6901","authenticated-orcid":false,"given":"Gaurang","family":"Sindhav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"issue":"D1","key":"581_CR1","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2012","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Soboleva A (2012) NCBI GEO: archive for functional genomics data sets\u2014update. Nucleic Acids Res 41(D1):D991\u2013D995","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"581_CR2","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.nmd.2019.10.010","volume":"29","author":"L Benarroch","year":"2019","unstructured":"Benarroch L, Bonne G, Rivier F, Hamroun D (2019) The 2020 version of the gene table of neuromuscular disorders. Neuromuscul Disord 29(12):980\u20131018","journal-title":"Neuromuscul Disord"},{"key":"581_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.phrs.2016.02.016","volume":"106","author":"RF Capogrosso","year":"2016","unstructured":"Capogrosso RF, Cozzoli A, Mantuano P, Camerino GM, Massari AM, Sblendorio VT, De Luca A (2016) Assessment of resveratrol, Apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of Duchenne muscular dystrophy: A comparison with the gold standard, \u03b1-methyl prednisolone. Pharmacol Res 106:101\u2013113","journal-title":"Pharmacol Res"},{"key":"581_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.freeradbiomed.2024.09.037","volume":"225","author":"D Cervia","year":"2024","unstructured":"Cervia D, Zecchini S, Pincigher L, Roux-Biejat P, Zalambani C, Catalani E, Perrotta C (2024) Oral administration of Plumbagin is beneficial in in vivo models of Duchenne muscular dystrophy through control of redox signaling. Free Radic Biol Med 225:193\u2013207","journal-title":"Free Radic Biol Med"},{"key":"581_CR5","doi-asserted-by":"publisher","first-page":"112233","DOI":"10.1016\/j.phytochem.2019.112233","volume":"171","author":"G Chen","year":"2020","unstructured":"Chen G, Zhao W, Li Y, Zhou D, Ding J, Lin B, Li N (2020) Bioactive chemical constituents from the seed testa of vernicia Fordii as potential neuroinflammatory inhibitors. Phytochemistry 171:112233","journal-title":"Phytochemistry"},{"key":"581_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY (2014) CytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol 8:1\u20137","journal-title":"BMC Syst Biol"},{"issue":"9","key":"581_CR7","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/ptr.4882","volume":"27","author":"HG Choi","year":"2013","unstructured":"Choi HG, Park YM, Lu Y, Chang HW, Na M, Lee SH (2013) Inhibition of prostaglandin D2 production by trihydroxy fatty acids isolated from ulmus Davidiana var. Japonica. Phytother Res 27(9):1376\u20131380","journal-title":"Phytother Res"},{"key":"581_CR8","doi-asserted-by":"publisher","first-page":"833833","DOI":"10.3389\/fbioe.2022.833833","volume":"10","author":"L Chung Liang","year":"2022","unstructured":"Chung Liang L, Sulaiman N, Yazid MD (2022) A decade of progress in gene-targeted therapeutic strategies in Duchenne muscular dystrophy: A systematic review. Front Bioeng Biotechnol 10:833833. https:\/\/doi.org\/10.3389\/fbioe.2022.833833","journal-title":"Front Bioeng Biotechnol"},{"key":"581_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","volume":"1418","author":"E Clough","year":"2016","unstructured":"Clough E, Barrett T (2016) The gene expression omnibus database. Methods Mol Biol 1418:93\u2013110. https:\/\/doi.org\/10.1007\/978-1-4939-3578-9_5","journal-title":"Methods Mol Biol"},{"issue":"6","key":"581_CR10","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1083\/jcb.200901052","volume":"185","author":"S Cohen","year":"2009","unstructured":"Cohen S, Brault JJ, Gygi SP, Glass DJ, Valenzuela DM, Gartner C, Goldberg AL (2009) During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J Cell Biol 185(6):1083\u20131095","journal-title":"J Cell Biol"},{"issue":"2","key":"581_CR11","doi-asserted-by":"publisher","first-page":"C616","DOI":"10.1152\/ajpcell.00425.2005","volume":"290","author":"OM Dorchies","year":"2006","unstructured":"Dorchies OM, Wagner S, Vuadens O, Waldhauser K, Buetler TM, Kucera P, Ruegg UT (2006) Green tea extract and its major polyphenol (\u2013)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy. Am J Physiology-Cell Physiol 290(2):C616\u2013C625","journal-title":"Am J Physiology-Cell Physiol"},{"issue":"1","key":"581_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan D, Goemans N, Takeda SI, Mercuri E, Aartsma-Rus A (2021) Duchenne muscular dystrophy. Nat Reviews Disease Primers 7(1):13","journal-title":"Nat Reviews Disease Primers"},{"doi-asserted-by":"crossref","unstructured":"Elasbali AM, Al-Soud WA, Adnan M, Alhassan HH, Mohammad T, Hassan MI (2024) Discovering promising biomarkers and therapeutic targets for Duchenne muscular dystrophy: A multiomics meta-analysis approach. Molecular Neurobiology, pp 1\u201312","key":"581_CR13","DOI":"10.1007\/s12035-023-03868-w"},{"issue":"1","key":"581_CR14","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/s42003-022-04212-z","volume":"5","author":"RA Ellwood","year":"2022","unstructured":"Ellwood RA, Slade L, Lewis J, Torregrossa R, Sudevan S, Piasecki M, Szewczyk NJ (2022) Sulfur amino acid supplementation displays therapeutic potential in a C. elegans model of Duchenne muscular dystrophy. Commun Biology 5(1):1255","journal-title":"Commun Biology"},{"issue":"1","key":"581_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12920-022-01388-5","volume":"15","author":"S Ghasemi","year":"2022","unstructured":"Ghasemi S, Mahdavi M, Maleki M, Salahshourifar I, Kalayinia S (2022) A novel likely pathogenic mutation in the FBXO32 gene associated with dilated cardiomyopathy according to whole-exome sequencing. BMC Med Genom 15(1):234. https:\/\/doi.org\/10.1186\/s12920-022-01388-5","journal-title":"BMC Med Genom"},{"issue":"10","key":"581_CR16","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/jamaneurol.2022.2480","volume":"79","author":"M Guglieri","year":"2022","unstructured":"Guglieri M, Clemens PR, Perlman SJ, Smith EC, Horrocks I, Finkel RS, Hoffman EP (2022) Efficacy and safety of Vamorolone vs placebo and prednisone among boys with Duchenne muscular dystrophy: A randomized clinical trial. JAMA Neurol 79(10):1005\u20131014","journal-title":"JAMA Neurol"},{"issue":"7","key":"581_CR17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nri2356","volume":"8","author":"JA Hamilton","year":"2008","unstructured":"Hamilton JA (2008) Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 8(7):533\u2013544","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"581_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","volume":"13","author":"DG Hardie","year":"2012","unstructured":"Hardie DG, Ross FA, Hawley SA (2012) AMPK: A nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 13(4):251\u2013262","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"581_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev.immunol.21.120601.140946","volume":"21","author":"ML Hermiston","year":"2003","unstructured":"Hermiston ML, Xu Z, Weiss A (2003) CD45: A critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 21(1):107\u2013137","journal-title":"Annu Rev Immunol"},{"issue":"4\u20135","key":"581_CR20","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.semcdb.2005.07.004","volume":"16","author":"CE Holterman","year":"2005","unstructured":"Holterman CE, Rudnicki MA (2005) Molecular regulation of satellite cell function. Semin Cell Dev Biol 16(4\u20135):575\u2013584","journal-title":"Semin Cell Dev Biol"},{"issue":"4","key":"581_CR21","doi-asserted-by":"publisher","first-page":"C834","DOI":"10.1152\/ajpcell.00579.2003","volume":"287","author":"RW Jackman","year":"2004","unstructured":"Jackman RW, Kandarian SC (2004) The molecular basis of skeletal muscle atrophy. Am J Physiology-Cell Physiol 287(4):C834\u2013C843. https:\/\/doi.org\/10.1152\/ajpcell.00579.2003","journal-title":"Am J Physiology-Cell Physiol"},{"issue":"4","key":"581_CR22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cardfail.2019.02.006","volume":"25","author":"H Jonathan","year":"2019","unstructured":"Jonathan H, Xu M, Slaughter JC, Crum K, Chew JD, Burnette WB, Markham LW (2019) The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in Duchenne muscular dystrophy cardiomyopathy. J Card Fail 25(4):259\u2013267","journal-title":"J Card Fail"},{"key":"581_CR23","doi-asserted-by":"publisher","first-page":"1180980","DOI":"10.3389\/fphys.2023.1180980","volume":"14","author":"K Kodippili","year":"2023","unstructured":"Kodippili K, Rudnicki MA (2023) Satellite cell contribution to disease pathology in Duchenne muscular dystrophy. Front Physiol 14:1180980","journal-title":"Front Physiol"},{"issue":"2","key":"581_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","volume":"26","author":"RA Laskowski","year":"1993","unstructured":"Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. Appl Crystallogr 26(2):283\u2013291","journal-title":"Appl Crystallogr"},{"issue":"1","key":"581_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1096\/fj.03-0610com","volume":"18","author":"SH Lecker","year":"2004","unstructured":"Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE, Goldberg AL (2004) Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18(1):39\u201351","journal-title":"FASEB J"},{"doi-asserted-by":"crossref","unstructured":"Lee JD, Woodruff TM (2021, December) The emerging role of complement in neuromuscular disorders. Seminars in immunopathology, vol 43. Springer, Berlin Heidelberg, pp 817\u2013828. 6","key":"581_CR26","DOI":"10.1007\/s00281-021-00895-4"},{"doi-asserted-by":"crossref","unstructured":"Li M, Han Y, Wang S, Yu Y, Liu M, Xia Y, Zha Y (2022) Becker muscular dystrophy: case report, review of the literature, and analysis of differentially expressed hub genes. Neurol Sci, 1\u201311","key":"581_CR27","DOI":"10.1007\/s10072-021-05499-2"},{"issue":"3","key":"581_CR28","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/nu13030998","volume":"13","author":"R Licitra","year":"2021","unstructured":"Licitra R, Marchese M, Brogi L, Fronte B, Pitto L, Santorelli FM (2021) Nutraceutical screening in a zebrafish model of muscular dystrophy: Gingerol as a possible food aid. Nutrients 13(3):998","journal-title":"Nutrients"},{"issue":"14","key":"581_CR29","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1093\/cvr\/cvab328","volume":"118","author":"CM Loescher","year":"2022","unstructured":"Loescher CM, Hobbach AJ, Linke WA (2022) Titin (TTN): from molecule to modifications, mechanics, and medical significance. Cardiovascular Res 118(14):2903\u20132918. https:\/\/doi.org\/10.1093\/cvr\/cvab328","journal-title":"Cardiovascular Res"},{"issue":"11","key":"581_CR31","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3390\/genes10110939","volume":"10","author":"SD Lombardo","year":"2019","unstructured":"Lombardo SD, Mazzon E, Mangano K, Basile MS, Cavalli E, Mammana S, Petralia MC (2019) Transcriptomic analysis reveals involvement of the macrophage migration inhibitory factor gene network in Duchenne muscular dystrophy. Genes 10(11):939","journal-title":"Genes"},{"issue":"4","key":"581_CR30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/genes12040543","volume":"12","author":"SD Lombardo","year":"2021","unstructured":"Lombardo SD, Basile MS, Ciurleo R, Bramanti A, Arcidiacono A, Mangano K, Fagone P (2021) A network medicine approach for drug repurposing in Duchenne muscular dystrophy. Genes 12(4):543","journal-title":"Genes"},{"key":"581_CR32","doi-asserted-by":"publisher","first-page":"116056","DOI":"10.1016\/j.biopha.2023.116056","volume":"170","author":"L Matias-Valiente","year":"2024","unstructured":"Matias-Valiente L, Sanchez-Fernandez C, Rodriguez-Outeiri\u00f1o L, Ramos MC, D\u00edaz C, Crespo G, Martinez A (2024) Evaluation of pro-regenerative and anti-inflammatory effects of isolecanoric acid in the muscle: potential treatment of Duchenne muscular dystrophy. Biomed Pharmacother 170:116056. https:\/\/doi.org\/10.1016\/j.biopha.2023.116056","journal-title":"Biomed Pharmacother"},{"issue":"7392","key":"581_CR33","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/nature10914","volume":"484","author":"T Metzger","year":"2012","unstructured":"Metzger T, Gache V, Xu M, Cadot B, Folker ES, Richardson BE, Baylies MK (2012) MAP and kinesin-dependent nuclear positioning is required for skeletal muscle function. Nature 484(7392):120\u2013124","journal-title":"Nature"},{"issue":"1","key":"581_CR34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3390\/ijms25010631","volume":"25","author":"M Molinaro","year":"2024","unstructured":"Molinaro M, Torrente Y, Villa C, Farini A (2024) Advancing biomarker discovery and therapeutic targets in Duchenne muscular dystrophy: A comprehensive review. Int J Mol Sci 25(1):631. https:\/\/doi.org\/10.3390\/ijms25010631","journal-title":"Int J Mol Sci"},{"issue":"10","key":"581_CR35","doi-asserted-by":"publisher","first-page":"e26169","DOI":"10.1371\/journal.pone.0026169","volume":"6","author":"C Moorwood","year":"2011","unstructured":"Moorwood C, Lozynska O, Suri N, Napper AD, Diamond SL, Khurana TS (2011) Drug discovery for Duchenne muscular dystrophy via utrophin promoter activation screening. PLoS ONE 6(10):e26169. https:\/\/doi.org\/10.1371\/journal.pone.0026169","journal-title":"PLoS ONE"},{"issue":"8","key":"581_CR36","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3390\/life11080827","volume":"11","author":"M Ogundele","year":"2021","unstructured":"Ogundele M, Zhang JS, Goswami MV, Barbieri ML, Dang UJ, Novak JS, Hathout Y (2021) Validation of chemokine biomarkers in Duchenne muscular dystrophy. Life 11(8):827","journal-title":"Life"},{"issue":"2","key":"581_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1254\/jphs.11077FP","volume":"118","author":"HM Oh","year":"2012","unstructured":"Oh HM, Lee SW, Park MH, Kim MH, Ryu YB, Kim MS, Rho MC (2012) Norkurarinol inhibits toll-like receptor 3 (TLR3)-mediated pro-inflammatory signaling pathway and rotavirus replication. J Pharmacol Sci 118(2):161\u2013170","journal-title":"J Pharmacol Sci"},{"issue":"12","key":"581_CR38","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s00424-021-02623-1","volume":"473","author":"K Ohlendieck","year":"2021","unstructured":"Ohlendieck K, Swandulla D (2021) Complexity of skeletal muscle degeneration: Multi-systems pathophysiology and organ crosstalk in dystrophinopathy. Pfl\u00fcgers Archiv - Eur J Physiol 473(12):1813\u20131839","journal-title":"Pfl\u00fcgers Archiv - Eur J Physiol"},{"doi-asserted-by":"crossref","unstructured":"Parolo S, Marchetti L, Lauria M, Misselbeck K, Scott-Boyer MP, Caberlotto L, Priami C (2018) Combined use of protein biomarkers and network analysis unveils deregulated regulatory circuits in Duchenne muscular dystrophy. PLoS ONE, 13(3), e0194225","key":"581_CR39","DOI":"10.1371\/journal.pone.0194225"},{"issue":"1","key":"581_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13395-015-0066-2","volume":"5","author":"F Pinto-Mariz","year":"2015","unstructured":"Pinto-Mariz F, Rodrigues Carvalho L, De Queiroz Campos Araujo P, De Mello A, Gon\u00e7alves W, Ribeiro M, Cunha MD C. S. A., Savino W (2015) CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy. Skelet Muscle 5(1):1\u201310","journal-title":"Skelet Muscle"},{"issue":"1","key":"581_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrm1004","volume":"4","author":"H Ponta","year":"2003","unstructured":"Ponta H, Sherman L, Herrlich PA (2003) CD44: from adhesion molecules to signaling regulators. Nat Rev Mol Cell Biol 4(1):33\u201345","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"581_CR42","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1681\/ASN.2010121308","volume":"22","author":"W Qin","year":"2011","unstructured":"Qin W, Chung ACK, Huang XR, Meng XM, Hui DSC, Yu CM, Lan HY (2011) TGF-\u03b2\/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol 22(8):1462\u20131474. https:\/\/doi.org\/10.1681\/ASN.2010121308","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"581_CR43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0972-2327.138508","volume":"17","author":"MV Rao","year":"2014","unstructured":"Rao MV, Sindhav GM, Mehta JJ (2014) Duchenne\/Becker muscular dystrophy: A report on clinical, biochemical, and genetic study in Gujarat population, India. Ann Indian Acad Neurol 17(3):303\u2013307","journal-title":"Ann Indian Acad Neurol"},{"issue":"5","key":"581_CR44","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000525045","volume":"85","author":"S Ren","year":"2022","unstructured":"Ren S, Yao C, Liu Y, Feng G, Dong X, Gao B, Qian S (2022) Antioxidants for treatment of Duchenne muscular dystrophy: A systematic review and meta-analysis. Eur Neurol 85(5):377\u2013388","journal-title":"Eur Neurol"},{"unstructured":"Rezaei N, Jabbari P (2022) Immunoinformatics of cancers. Practical machine learning approaches using R. Academic","key":"581_CR45"},{"key":"581_CR46","doi-asserted-by":"publisher","first-page":"1395014","DOI":"10.3389\/fphar.2024.1395014","volume":"15","author":"M Saeed","year":"2024","unstructured":"Saeed M, Haque A, Shoaib A, Danish Rizvi SM (2024) Exploring novel natural compound-based therapies for Duchenne muscular dystrophy management: insights from network pharmacology, QSAR modeling, molecular dynamics, and free energy calculations. Front Pharmacol 15:1395014","journal-title":"Front Pharmacol"},{"issue":"21","key":"581_CR47","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1093\/hmg\/ddy288","volume":"27","author":"R Sagheddu","year":"2018","unstructured":"Sagheddu R, Chiappalupi S, Salvadori L, Riuzzi F, Donato R, Sorci G (2018) Targeting RAGE as a potential therapeutic approach to Duchenne muscular dystrophy. Hum Mol Genet 27(21):3734\u20133746","journal-title":"Hum Mol Genet"},{"doi-asserted-by":"publisher","unstructured":"Sandri M, Lin J, Handschin C, Yang W, Arany Z. P., Lecker S. H., Goldberg A. L., Spiegelman B. M. (2004) PGC-1\u03b1 protects skeletal muscle from atrophy by suppressing FoxO3 action. Proc Natl Acad Sci 101(17):12682\u201312687. https:\/\/doi.org\/10.1073\/pnas.0406743101","key":"581_CR48","DOI":"10.1073\/pnas.0406743101"},{"issue":"1","key":"581_CR49","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41467-020-20123-1","volume":"12","author":"R Sartori","year":"2021","unstructured":"Sartori R, Romanello V, Sandri M (2021) Mechanisms of muscle atrophy and hypertrophy: implications in health and disease. Nat Commun 12(1):330","journal-title":"Nat Commun"},{"issue":"1","key":"581_CR50","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40203-024-00218-z","volume":"12","author":"S Shah","year":"2024","unstructured":"Shah S, Trivedi P, Ghanchi M, Sindhav G, Doshi H, Verma RJ (2024) Systems biology approach: identification of hub genes, signaling pathways, and molecular Docking of COL1A1 gene in cervical insufficiency. Silico Pharmacol 12(1):45","journal-title":"Silico Pharmacol"},{"issue":"11","key":"581_CR51","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498\u20132504","journal-title":"Genome Res"},{"issue":"17","key":"581_CR52","doi-asserted-by":"publisher","first-page":"6524","DOI":"10.1080\/07391102.2020.1801507","volume":"39","author":"P Sharma","year":"2021","unstructured":"Sharma P, Joshi T, Joshi T, Chandra S, Tamta S (2021) Molecular dynamics simulation for screening phytochemicals as \u03b1-amylase inhibitors from medicinal plants. J Biomol Struct Dynamics 39(17):6524\u20136538. https:\/\/doi.org\/10.1080\/07391102.2020.1801507","journal-title":"J Biomol Struct Dynamics"},{"issue":"4","key":"581_CR53","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1089\/scd.2020.0161","volume":"30","author":"M Siemionow","year":"2021","unstructured":"Siemionow M, Szilagyi E, Cwykiel J, Domaszewska-Szostek A, Heydemann A, Garcia-Martinez J, Siemionow K (2021) Transplantation of dystrophin-expressing chimeric human cells of myoblast\/mesenchymal stem cell origin improves function in Duchenne muscular dystrophy model. Stem Cells Dev 30(4):190\u2013202","journal-title":"Stem Cells Dev"},{"doi-asserted-by":"crossref","unstructured":"Sitzia, C., Farini, A., Colleoni, F., Fortunato, F., Razini, P., Erratico, S.,\u2026 Torrente,Y. (2015). Improvement of endurance of DMD animal model using natural polyphenols.BioMed Research International, 2015(1), 680615.","key":"581_CR54","DOI":"10.1155\/2015\/680615"},{"issue":"3","key":"581_CR55","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/s1097-2765(04)00211-4","volume":"14","author":"TN Stitt","year":"2004","unstructured":"Stitt TN, Drujan D, Clarke BA, Panaro FJ, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ (2004) The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14(3):395\u2013403. https:\/\/doi.org\/10.1016\/s1097-2765(04)00211-4","journal-title":"Mol Cell"},{"doi-asserted-by":"crossref","unstructured":"Sun, C., Choi, I. Y., Gonzalez, Y. I. R., Andersen, P., Talbot, C. C., Jr., Iyer,S. R.,\u2026 Lee, G. (2020). Duchenne muscular dystrophy hiPSC-derived myoblast drug screen identifies compounds that ameliorate disease in mdx mice. JCI Insight, 5(11).","key":"581_CR56","DOI":"10.1172\/jci.insight.134287"},{"issue":"8","key":"581_CR57","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3390\/genes11080837","volume":"11","author":"C Sun","year":"2020","unstructured":"Sun C, Shen L, Zhang Z, Xie X (2020) Therapeutic strategies for Duchenne muscular dystrophy: an update. Genes 11(8):837. https:\/\/doi.org\/10.3390\/genes11080837","journal-title":"Genes"},{"issue":"5","key":"581_CR58","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.apsb.2020.01.001","volume":"10","author":"I Suntar","year":"2020","unstructured":"Suntar I, Sureda A, Belwal T, Sanches Silva A, Vacca RA, Tewari D et al (2020) Natural products, PGC-1\u03b1, and Duchenne muscular dystrophy. Acta Pharm Sinica B 10(5):734\u2013745. https:\/\/doi.org\/10.1016\/j.apsb.2020.01.001","journal-title":"Acta Pharm Sinica B"},{"key":"581_CR59","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10086-016-1563-6","volume":"62","author":"T Suzuki","year":"2016","unstructured":"Suzuki T, Eto K, Kubota Y, Katayama T, Pankasemsuk T (2016) Antioxidative catechol lignans\/neolignans isolated from defatted kernel of Jatropha Curcas. J Wood Sci 62:339\u2013348","journal-title":"J Wood Sci"},{"unstructured":"Trivedi PG, Gajera JB, Ghanchi FI, Sindhav GM (2023) Simultaneous detection of thirteen exons of dystrophin gene by optimized multiplex PCR assay to screen Duchenne\/Becker muscular dystrophy","key":"581_CR60"},{"issue":"7","key":"581_CR61","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41582-019-0203-3","volume":"15","author":"IE Verhaart","year":"2019","unstructured":"Verhaart IE, Aartsma-Rus A (2019) Therapeutic developments for Duchenne muscular dystrophy. Nat Reviews Neurol 15(7):373\u2013386","journal-title":"Nat Reviews Neurol"},{"key":"581_CR62","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.omtn.2018.02.004","volume":"11","author":"M Wang","year":"2018","unstructured":"Wang M, Wu B, Shah SN, Lu P, Lu Q (2018) Saponins as natural adjuvant for antisense morpholino oligonucleotides delivery in vitro and in Mdx mice. Mol Therapy Nucleic Acids 11:192\u2013202","journal-title":"Mol Therapy Nucleic Acids"},{"issue":"11","key":"581_CR63","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/nu8110713","volume":"8","author":"KG Woodman","year":"2016","unstructured":"Woodman KG, Coles CA, Lamand\u00e9 SR, White JD (2016) Nutraceuticals and their potential to treat Duchenne muscular dystrophy: separating the credible from the conjecture. Nutrients 8(11):713","journal-title":"Nutrients"},{"doi-asserted-by":"crossref","unstructured":"Xin J, Liu S (2024) Identifying hub genes and dysregulated pathways in Duchenne muscular dystrophy. Int J Neurosci, 1\u201313","key":"581_CR64","DOI":"10.1080\/00207454.2024.2302551"},{"doi-asserted-by":"crossref","unstructured":"Xu X, Hao Y, Wu J, Zhao J, Xiong S (2021) Assessment of weighted gene co-expression network analysis to explore key pathways and novel biomarkers in muscular dystrophy. Pharmacogenomics Personalized Med, 431\u2013444","key":"581_CR65","DOI":"10.2147\/PGPM.S301098"},{"doi-asserted-by":"crossref","unstructured":"Yao, S., Chen, Z., Yu, Y., Zhang, N., Jiang, H., Zhang, G.,\u2026 Zhang, B. (2021). Current pharmacological strategies for Duchenne muscular dystrophy. Frontiers in Cell and Developmental Biology, 9, 689533.","key":"581_CR66","DOI":"10.3389\/fcell.2021.689533"},{"issue":"1","key":"581_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/cmb.2019.0167","volume":"27","author":"R Zhang","year":"2020","unstructured":"Zhang R, Lv L, Ban W, Dang X, Zhang C (2020) Identification of hub genes in Duchenne muscular dystrophy: evidence from bioinformatic analysis. J Comput Biol 27(1):1\u20138","journal-title":"J Comput Biol"},{"issue":"D1","key":"581_CR68","doi-asserted-by":"publisher","first-page":"D621","DOI":"10.1093\/nar\/gkac113","volume":"51","author":"H Zhao","year":"2023","unstructured":"Zhao H, Yang Y, Wang S, Yang X, Zhou K, Xu C et al (2023) NPASS database update 2023: quantitative natural product activity and species source database for biomedical research. Nucleic Acids Res 51(D1):D621\u2013D628. https:\/\/doi.org\/10.1093\/nar\/gkac113","journal-title":"Nucleic Acids Res"}],"container-title":["Network Modeling Analysis in Health Informatics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-025-00581-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13721-025-00581-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-025-00581-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:55:17Z","timestamp":1757350517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13721-025-00581-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["581"],"URL":"https:\/\/doi.org\/10.1007\/s13721-025-00581-7","relation":{},"ISSN":["2192-6670"],"issn-type":[{"type":"electronic","value":"2192-6670"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}